Astal Laboratories Limited (BOM:512600)
81.70
+3.18 (4.05%)
At close: Aug 21, 2026
Astal Laboratories Revenue
Astal Laboratories had revenue of 998.98M INR in the quarter ending June 30, 2026, with 298.29% growth. This brings the company's revenue in the last twelve months to 3.22B, up 325.99% year-over-year. In the fiscal year ending March 31, 2026, Astal Laboratories had annual revenue of 2.47B with 288.52% growth.
Revenue (ttm)
3.22B
Revenue Growth
+325.99%
P/S Ratio
1.11
Revenue / Employee
n/a
Employees
n/a
Market Cap
3.57B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 2.47B | 1.84B | 288.52% |
| Mar 31, 2025 | 636.55M | 400.05M | 169.15% |
| Mar 31, 2024 | 236.50M | 200.44M | 555.71% |
| Mar 31, 2023 | 36.07M | 33.96M | 1,611.01% |
| Mar 31, 2022 | 2.11M | 77.20K | 3.80% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Niyogin Fintech | 2.71B |
| Sobhagya Mercantile | 2.19B |
| Swojas Foods | 1.46B |
| Sera Investments & Finance India | 1.28B |
| Regency Fincorp | 350.68M |
| DhanSafal Finserve | 140.10M |
| Toyam Sports | 9.17M |
| TruCap Finance | -824.48M |